Innovative Pharmaceutical Biotech Limited announced that as the auditing process for the audited final results for the year ended 31 March 2022 has not been completed due to the impact of the COVID-19 epidemic which restricts the auditors to gather necessary direct external confirmations. Accordingly, the Company's auditors require additional time for completing their audit work. The unaudited consolidated results contained herein is made by the Board only based on the unaudited management accounts of the Group for the year ended 31 March 2022 and have been reviewed by the audit committee of the Company, which have not been reviewed or audited by the auditors of the Company.

An announcement relating to the audited final results will be made by no later than 29 July 2022 when the auditing process has been completed.